Aiza Ahsan

Carvedilol for prevention of cardiotoxicity in patients receiving anthracycline-based chemotherapy: a systematic review and meta-analysis

Chemotherapy-induced cardiotoxicity, particularly from anthracyclines, limits treatment in oncology patients. Carvedilol, a third-generation β-blocker with antioxidant properties, may offer cardio protection. However, comparative evidence for carvedilol and its metabolites remain...